AAAAAA

   
Results: 1-7 |
Results: 7
Clinical utility of scram HER-2/neu testing on the Bayer Immuno 1 (R) automated system in breast cancer
Authors: Cook, GB Neaman, IE Goldblatt, JL Cambetas, DR Hussain, M Luftner, D Yeung, KK Chan, DW Schwartz, MK Allard, WJ
Citation: Gb. Cook et al., Clinical utility of scram HER-2/neu testing on the Bayer Immuno 1 (R) automated system in breast cancer, ANTICANC R, 21(2B), 2001, pp. 1465-1470
Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.
Authors: Okihara, K Fritsche, HA Ayala, A Johnston, DA Allard, WJ Babaian, RJ
Citation: K. Okihara et al., Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml., J UROL, 165(6), 2001, pp. 1930-1936
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer
Authors: Brawer, MK Cheli, CD Neaman, IE Goldblatt, J Smith, C Schwartz, MK Bruzek, DJ Morris, DL Sokoll, LJ Chan, DW Yeung, KK Partin, AW Allard, WJ
Citation: Mk. Brawer et al., Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer, J UROL, 163(5), 2000, pp. 1476-1480
Binding characteristics of CA 15-3 assay antibodies DF3 and 115D8 to MUC1 mucin
Authors: Dai, J Belenky, A Davis, G Yeung, KK Allard, WJ
Citation: J. Dai et al., Binding characteristics of CA 15-3 assay antibodies DF3 and 115D8 to MUC1 mucin, J CLIN LIG, 22(1), 1999, pp. 78-85
Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen
Authors: Stenman, UH Paus, E Allard, WJ Andersson, I Andres, C Barnett, TR Becker, C Belenky, A Bellanger, L Pellegrino, CM Bormer, OP Davis, G Dowell, B Grauer, LS Jette, DC Karlsson, B Kreutz, FT van der Kwast, TM Lauren, L Leinimaa, M Leinonen, J Lilja, H Linton, HJ Nap, M Nilsson, O Ng, PC Nustad, K Peter, A Pettersson, K Piironen, T Rapp, J Rittenhouse, HG Rye, PD Seguin, P Slota, J Sokoloff, RL Suresh, MR Very, DL Wang, TJ Wigheden, I Wolfert, RL Yeung, KK Zhang, WM Zhou, Z Hilgers, J
Citation: Uh. Stenman et al., Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 1-12
Analysis of monoclonal antibodies to prostate-specific antigen: Reactivitywith native and recombinant prostate-specific antigen
Authors: Zhou, Z Barnett, TR Very, DL Ng, PC Pellegrino, CM Davis, G Belenky, A Allard, WJ Yeung, KK
Citation: Z. Zhou et al., Analysis of monoclonal antibodies to prostate-specific antigen: Reactivitywith native and recombinant prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 86-93
Measurement of four tumor marker antigens in the sera of pregnant women
Authors: Cheli, CD Morris, DL Neaman, IE Dai, J Allard, WJ Yeung, KK
Citation: Cd. Cheli et al., Measurement of four tumor marker antigens in the sera of pregnant women, J CL LAB AN, 13(1), 1999, pp. 35-39
Risultati: 1-7 |